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Analysis of aged and cataract lenses shows the presence of
increased amounts of crystallin fragments in the high molec-
ular weight aggregates of water-soluble and water-insoluble
fractions. However, the significance of accumulation and
interaction of low molecular weight crystallin fragments in
aging and cataract development is not clearly understood. In
this study, 23 low molecular mass (<3.5-kDa) peptides in the
urea-soluble fractions of young, aged, and aged cataract human
lenses were identified by mass spectroscopy. Two peptides,
B-(1–18) (MDIAIHHPWIRRPFFPFH) and A3/A1-(59–74)
(SD(N)AYHIERLMSFRPIC), present in aged and cataract lens
but not young lens, and a third peptide, S-(167–178)
(SPAVQSFRRIVE) present in all three lens groups were synthe-
sized to study the effects of interaction of these peptides with
intact -, -, and -crystallins and alcohol dehydrogenase, a
protein used in aggregation studies. Interaction of B-(1–18)
and A3/A1-(59–74) peptides increased the scattering of light
by- and-crystallin and alcohol dehydrogenase. The ability of
-crystallin subunits to function as molecular chaperones was
significantly reduced by interaction with B-(1–18) and A3/
A1-(59–74) peptides, whereasS peptide hadno effect on chap-
erone-like activity of -crystallin. The A3/A1-(59–74 peptide
caused a 5.64-fold increase inB-crystallin oligomericmass and
partial precipitation. Replacing hydrophobic residues inB-(1–
18) and A3/A1-(59–74) peptides abolished their ability to
induce crystallin aggregation and light scattering. Our study
suggests that interaction of crystallin-derived peptides with
intact crystallins could be a key event in age-related protein
aggregation in lens and cataractogenesis.
Lens proteins undergo very little turnover after synthesis, but
they undergo various changes during aging and cataractogen-
esis (1). Certain post-translational modifications appear to be
part of the normal maturation process (2, 3), and other modifi-
cations, including deamidation, phosphorylation, truncation,
glycation, oxidation, and cross-linking, are seen in aged and
cataractous lenses (4). Changes in the structure and solubility of
lens proteins depend on the extent and nature of the modifica-
tion. Lens opacification is primarily due to the insolubilization
of crystallins, proteins that are essential for maintaining the
optical properties of the lens.
Crystallin proteolysis is significantly increased in aged and
cataract human lenses as compared with young human lenses
(5–8). Increased crystallin fragmentation in aged and cataract
lenses has also been reported in nonhuman species (3, 9–12).
Unregulated proteolysis of crystallins is suggested to be one of
the cause for crystallin insolubilization (13). Several proteolytic
enzymes have been shown to play a role in aging of the lens and
cataract formation (14–20). Degradation of lens crystallins by
proteolytic enzymes can damage their highly ordered arrange-
ments. An age-related decrease in the levels or activities of pro-
teases could result in the accumulation of modified proteins
(21, 22). Although a protein oxidation reaction may convert
proteins to forms that are more susceptible to proteolytic deg-
radation, the oxidized forms of some proteins not only are
resistant to proteolytic degradation but also may inhibit the
ability of some proteases to degrade the oxidized forms of other
proteins. The protein-protein cross-linked derivatives have
been found to resist proteolytic degradation and to inhibit the
ability of the 20 S proteosome to degrade the oxidized forms of
other proteins (23).
Crystallin fragments are present in water-soluble and water-
insoluble factions of the lens, with more prevalence in the
water-insoluble fractions (6, 24, 25). As many as 13 crystallin
fragments with molecular masses between 3 and 17 kDa origi-
nating from -, -, and -crystallins have been isolated from
the water-soluble high molecular weight aggregates of 60–80-
year-old human lens (26). Understanding the interaction
between the lens proteins and the crystallin fragments is the key
to assessing the consequence of incomplete proteolytic degra-
dation. Protein aggregation in the lens increases with age, lead-
ing to the accumulation of high molecular weight aggregates
that scatter light. Although it is hypothesized that cataract
develops as a result of the improper interaction of crystallin
fragments generated by proteolysis (17), the mechanism by
which crystallin fragments initiate or influence the process of
lens protein aggregation to form high molecular weight
aggregates is not clear. Earlier, we showed that in vitro oxi-
dized crystallin peptides enhance the aggregation of L-crys-
tallin and -crystallin and also exhibit an anti-chaperone-
like property (27–29). Peptide interactions with lens
proteins and the aggregation-facilitating nature of lens pep-
tides may be important in age-related cataract formation,
where lens proteins undergo incomplete proteolysis and
peptide fragments tend to accumulate.
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The present study was performed to identify crystallin frag-
ments in young, aged, and cataract human lenses and investi-
gate their possible role in crystallin aggregation and light scat-
tering. Our data show that peptides generated in the lens
interact with crystallins and increase their aggregation and pre-
cipitation. The results also demonstrate that crystallin peptides
generated in vivo exhibit anti-chaperone-like activity.
EXPERIMENTAL PROCEDURES
Materials—B-crystallin peptide (1MDIAIHHPWIRRPFF-
PFH18) (peptide A),A3/A1-crystallin peptide (59SD(N)AYHI-
ERLMSFRPIC74) (peptide B), and S-crystallin peptide
(167SPAVQSFRRIVE178) (peptide G) and the mutant peptides
were synthesized at the University of Missouri-Columbia core
facility. The protease inhibitor mixture was obtained from Cal-
biochem. Alcohol dehydrogenase (ADH)2 was obtained from
Biozyme Laboratories (San Diego, CA). All other chemicals
were of analytical grade and from Sigma unless otherwise
noted.
Lenses—Human donor lenses were obtained from the Lions
Eye Tissue Bank (Columbia, MO) and kept at70 °C until use.
Lenses were separated based on their age and color. Four lenses
were analyzed from each group: young lenses (18–32 years),
aged lenses (75–95 years), and aged cataract lenses. Young (2
years old) bovine lenses were obtained fromPel-Freeze Biologi-
cals (Rogers, AR) and stored at70 °C until use.
Isolation and Identification of Peptides from Human Lens—
Lenses were homogenized in 1 ml of 0.05 M phosphate buffer
(pH 7.4) containing 0.1 M NaCl, 6 M urea, and 2 mM tris(2-
carboxyethyl)phosphine hydrochloride (Pierce) and in the
presence of 5 l of protease inhibitor mixture. The sample was
centrifuged at 16,000 g for 1 h. The urea-soluble fraction was
collected and filtered through a 10 kDa Centriplus filter (Milli-
pore). The low molecular weight (LMW) peptides that were
present in the filtrate were desalted using PepClean C-18 spin
columns (Pierce). The bound peptides were eluted by 70% ace-
tonitrile containing 1% formic acid. The eluted peptides were
analyzed byABIVoyagerDE PROmatrix-assisted laser desorp-
tion time of flight mass spectrometry (MALDI-TOF MS) and
nanoelectrospray ionization quadrupole time-of-flight tandem
mass spectrometry to identify and sequence the peptide ions.
The low molecular weight fractions prepared from young,
old, and cataract human lenses as above was dialyzed exten-
sively using 1-kDa cut-off dialysis tubing, concentrated, and
used in quantifying the relative light scattering activity in an
aggregation assay.
Preparation of Peptides—The synthetic peptides obtained
from the core facility were purified by reverse-phase high per-
formance liquid chromatography on a C-18 column. The pep-
tidemass and sequenceswere confirmedbymass spectrometric
analysis at the University of Missouri-Columbia Proteomics
Center. The purified peptides were dissolved in a small volume
of Me2SO and equilibrated with 0.05 M phosphate buffer con-
taining 0.15 M NaCl (pH 7.4) using 1-kDa dialysis membrane.
The peptide concentration in the dialyzed sample was meas-
ured using a micro-BCA protein assay kit (Pierce).
Regional Distribution of LMW Peptides—A pair of 75-year-
old lenses was used tomeasure the peptide concentration in the
cortex and nucleus of aged human lens. The lens was thawed,
and the capsule was carefully removed using a forceps. The
outer cortex and inner nucleus were separated using themicro-
stir bar in a glass vial using 0.05 M phosphate buffer containing
6 M urea, 2 mM tris(2-carboxyethyl)phosphine hydrochloride
and protease inhibitor mixture (20 l/5 ml of buffer), pH 7.4.
The lenses were stirred for about 3 min in 0.5 ml of buffer to
solubilize the cortex. The nucleus was homogenized using a
micro-tissue homogenizer using the same buffer. The sample
volume was adjusted to 1.5 ml with homogenization buffer and
centrifuged at 13,000 g to remove the urea-insoluble fraction.
0.5 ml of the supernatant from the cortex and nucleus fraction
was passed through 10 kDa cut-off filter to obtain the LMW
peptides. 30 l of the filtrate containing LMW peptides was
desalted using PepClean spin column and analyzed byMALDI-
TOF MS.
Purification of Crystallins—-Crystallin, -crystallin, and
-crystallin were separated from the water-soluble fractions of
young bovine lens cortex by gel filtration on a Sephadex G-200
column (30). -Crystallin was further purified on a trimethyl-
aminoethyl fractogel ion exchange column, as described previ-
ously (29). L-Crystallin peak fractions were pooled, concen-
trated, and used without further purification. -Crystallin was
isolated from bovine lens extract by means of Sephadex G-200
and Biogel P-30 chromatography, as described previously (31).
The protein concentration was measured using a BCA protein
assay kit. Recombinant human A- and B-crystallins were
expressed in Escherichia coli BL21(DE3)pLysS cells (Invitro-
gen) and purified using gel filtration and anion exchange chro-
matography, as described previously (32).
Interaction between Crystallin Peptides and Intact
Crystallins—Interactions between intact -, -, and -crystal-
lins and crystallin peptides A, B, and G were verified using
HPLC and SDS-PAGE analysis.
Recombinant A-crystallin (250 g) was incubated with 100
g of peptide A, B, or G, in a total volume of 0.5 ml of 50 mM
phosphate buffer containing 150 mM NaCl (pH 7.4) at 37 °C.
Samples that containedA-crystallin or peptide alone served as
control. After 4 h of incubation, the samples were briefly cen-
trifuged to separate any visible precipitate. Supernatant (350
l) was injected into a TSK G5000PWXL (Tosoh Bioscience,
Montgomeryville, PA) size exclusion column fitted to anHPLC
system with a UV detector and equilibrated with phosphate
buffer. The peak containing the A-crystallin-peptide complex
was pooled, concentrated, and analyzed on 4–20% Tris-HCl
SDS-polyacrylamide gel (Bio-Rad) electrophoresis.
The interactions of L- and -crystallin with each peptide
were assessed by incubating 250g of the crystallinwith 100g
of the peptide at 55 °C for 1 h. Crystallin by itself was used as a
control. At the end of incubation, the aggregated protein was
collected by centrifugation at 15,000 g. The precipitated pro-
tein was washed with deionized water and centrifuged to
remove any soluble proteins or peptides. The procedure was
repeated twice. The collected precipitate was solubilized in 200
2 The abbreviations used are: ADH, alcohol dehydrogenase; MALDI-TOF,
matrix-assisted laser desorption time-of-flight; MS, mass spectrometry;
LMW, lowmolecular weight; HPLC, high pressure liquid chromatography.
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l of freshly prepared 6 M urea and diluted with water until the
samplemeasured 1ml. The sample was injected onto a reverse-
phase analytical C-18 column (Vydac) equilibrated with water
containing 0.1% trifluoroacetic acid. The L-crystallin subunits
and the peptides were separated using acetonitrile gradient
(5–80%).
Light ScatteringMeasurements—The effects of peptide inter-
action on the molecular mass and the hydrodynamic radius of
B-crystallin were studied using static and dynamic light scat-
tering. Recombinant B-crystallin (300 g) was incubated at
37 °C for 4 hwith an equal amount (weight) of the peptide in 0.5
ml of 0.05 M phosphate buffer (pH 7.2) containing 0.15 M NaCl.
At the end of incubation, the samples were centrifuged to
remove visible precipitates. Supernatant (150 l) was injected
into a TSK G5000PWXL (Tosoh Bioscience) size exclusion col-
umn fitted to a high pressure liquid chromatograph with a
refractive index detector (Shimadzu, Columbia,MD) and equil-
ibrated with the incubation buffer. The HPLC was coupled to
multiangle light scattering and quasielastic light scattering
detectors (Wyatt Technology Corp., Santa Barbara, CA). Data
were analyzed using ASTRA (5.1.9) software developed by
Wyatt Technology.
ThermalDenaturation and Light Scattering Assay—Thermal
aggregation assay of L-crystallin, -crystallin, and ADH and
chaperone assay of -crystallin were performed according to
themethod described previously (29, 32). Briefly, substrate pro-
tein L-crystallin (100 g) or -crystallin (100 g) was heat-
denatured at 55 °C in 1 ml of 0.05 M phosphate buffer, pH 7.4.
Aggregation and light scattering were monitored at 360 nm.
Different concentrations of peptide A, peptide B, and peptideG
were included in the assay mixture to determine their effect on
substrate protein aggregation. A similar experiment was per-
formed following incubation at 37 °C for 10 h to study the effect
of each peptide on L-crystallin aggregation at physiological
temperature. To study the anti-chaperone activity of low
molecular weight peptides, known concentrations of peptides
A, B, andGwere included in the assaymixture alongwith chap-
erone protein, -crystallin, and substrate protein. Aggregation
and light scattering were monitored as described above. To
determine the specificity of these peptides in influencing pro-
tein aggregation, a fewmutants of peptideA and peptide Bwere
used to study their effects on protein aggregation and light scat-
tering. ADH (250 g) was chosen as a noncrystallin substrate
protein to study the interaction with crystallin fragments.
RESULTS
Water-soluble protein fractions fromyoung and aged human
lenses were subjected to size exclusion chromatography cou-
pled with dynamic light scattering analysis. We observed that,
compared with the water-soluble fraction of young lens, the
protein concentration in the water-soluble fraction of aged lens
was decreased, whereas the mass distribution was increased
(Fig. 1). The aged lens had soluble aggregates as large as 3500
kDa in contrast to soluble aggregates of 2000 kDa in the young
lens.
LowMolecularWeight Crystallin from Lenses Enhances Light
Scattering by Denaturing Protein—Wemeasured the light scat-
tering ability of lowmolecular weight fractions (1–10-kDa frac-
tions) isolated from young, adult, aged, and cataract human
lenses using an ADH aggregation assay. As shown in the Table
1, the crystallin fragments present in 1–10-kDa fractions from
young lenses showed the lowest light scattering activity com-
pared with aged and cataract lens fractions. The cataract and
aged lenses (70 years) showed 4.4–4.6-fold greater light scat-
tering activity in them compared with young (14- and 16-year)
lenses.
Identification of Crystallin Peptides from Human Lenses—
The low molecular weight peptide profiles of young, aged, and
cataract lenses analyzed by MALDI-TOFMS are shown in Fig.
2,A–C, respectively.Within each lens group, theMALDI-TOF
peptide profiles were comparable. The number of peptides in
young lenses was less than that in aged lenses. Peptide signals
were prominent in aged and cataract lenses but not in young
lenses, suggesting that the total peptide concentration is higher
in aged and cataract lenses than in young lenses. Peptide con-
centrations, determined in a single lens from each group, were
0.29, 0.9, and 1.1 mg/lens in young, aged, and cataract lenses,
respectively. Peptides that were common to each group of
lenses and smaller than 3500 Da were analyzed by nanoelectro-
FIGURE 1. Mass distribution in the water-soluble fraction in young (19
years) (solid line and filled circle) and aged (83 years) (broken line and
open circle) human lenses usingmultiangle light scattering. The samples
(250g of proteins) were injected into a high pressure liquid chromatograph
fitted with a TSK G5000PWXL size exclusion column and refractive index
detector, coupledwithmultiangle light scattering and quasielastic light scat-
tering detectors. The mobile phase contained 0.05 M sodium phosphate and
0.15 M sodium chloride, pH 7.2. The mass was determined using ASTRA
software.
TABLE 1
Effect of whole lens lowmolecular weight fraction on protein
aggregation
The relative light scattering activity of lowmolecular weight fractionswas estimated
by the ADH aggregation assay described earlier (32). Lowmolecular weight crystal-
lin fragments from the I–IV groups of lenses were concentrated to a final volume of
150 l/lens, and 25-l samples were used in assays. The result shown is an average
from two assays. Group IV lenses are cataract lenses showing nuclear opacity with
moderate yellow discoloration, similar to that observed in group III lenses.
Group
(age in years)
Increase in
light scattering
Relative light
scattering activity
%
I (14 and 16) 5 1.0
II (41 and 42) 9 1.8
III (70) 23 4.6
IV (70, 75, 79, and 89) 22 4.4
Crystallin Fragments Accelerate Aging and Cataract Development
MARCH 28, 2008•VOLUME 283•NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 8479
 at University of M
issouri-Colum
bia, on O
ctober 27, 2009
w
w
w
.jbc.org
D
ow
nloaded from
 
spray ionization quadrupole time-of-flight tandem mass spec-
trometry to determine the sequence and origin of peptides. The
peptides that were found in the young, aged, and aged cataract
lenses and sequenced from MS/MS analysis are listed in Table
2. The GenBankTM accession numbers used to match the
sequence of crystallin peptides are given in Table 2. The
A3/A1 peptide sequence was numbered based on a truncated
A3/A1 sequence submitted to GenBankTM. The data indicate
that crystallin fragments are generated from allmajor lens crys-
tallins. Sequences could not be assigned to less abundant pep-
tides identified by MALDI-TOF MS, and these peptides were
excluded from the Table 2. Analysis of a 75-year-old lens
showed that the concentration of LMW peptides is higher in
the nucleus (931 g) than in the outer cortex (338 g). We also
observed a differential distribution of individual peptides in the
cortex and nucleus based on theMALDI-TOFMS signal inten-
sity (data not shown). The signal intensity of A-(43–56) and
B-(45–57) peptides was highest and quite prominent in the
cortex. However, in the nucleus, these peptides had a weak sig-
nal (4% of their signal intensity in the cortex). The peptides A,
B, and A-(66–80) were found only in the nucleus. Other pep-
tides, including peptide G, were present in both regions, but
their signal intensities were 5–10-fold higher in the nucleus.
In vitro oxidized crystallin peptides were shown in our pre-
vious studies to interact with lens crystallins and to influence
their aggregation and light scattering (27–29). The present
study investigated whether in vivo found crystallin frag-
ments interact with lens crystallins and produce similar
effects on aggregation and light scattering. We selected the
following three peptides for further study: B-crystallin pep-
tide (1MDIAIHHPWIRRPFFPFH18), A3/A1-crystallin pep-
tide (59SD(N)AYHIERLMSFRPIC74), and S-crystallin peptide
(167SPAVQSFRRIVE178), named peptideA, peptide B, and pep-
tide G, respectively, based on the crystallin protein from which
they were derived. A deamidated form of A3/A1-(59–74) was
used as peptide B. Peptides A and B are found only in the aged
and cataract lenses, and peptideG is present in young, aged, and
cataract lenses.
FIGURE2.MALDI-TOF-MSof lowmolecularweightpeptides isolated from
young (32 years) (A), aged (94 years) (B), and cataract (87 years) (C)
human lenses.
TABLE 2
Lowmolecular weight peptides identified in the young, aged, and cataract human lenses using MALDI-TOF MS and quadrupole time-of-flight
MS/MS
Peptides shown in boldface type were used in the current study. The peptide sequence was numbered based on the GenBankTM accession number given in the table.
Peptide mass Source Accession number Found in Peptide sequence fromMS/MS analysisYoung Aged Cataract
922.43 B-(59–66) NP_001876 No Yes Yes PSWFDTGL
1152.64 A-(67–75) NP_000385 Yes No No DRDKFVIFL
1239.67 A-(66–75) NP_000385 No Yes Yes SDRDKFVIFL
1381.64 B-(24–34) NP_001876 No No Yes FDQFFGEHLLE
1388.77 S-(167–178) NP_060011 Yes Yes Yes SPAVQSFRRIVE
1426.75 A-(2–12) NP_000385 No Yes Yes DVTIQHPWFKR
1527.81 A-(2–13) NP_000385 No Yes Yes DVTIQHPWFKRT
1550.84 B-(45–57) NP_001876 Yes Yes No SPFYLRPPSFLRA
1730.96 A-(43–56) NP_000385 Yes Yes Yes TISPYYRQSLFRTV
1778.91 A-(67–80) NP_000385 No Yes Yes DRDKFVIFLDVKHF
1835.01 A-(51–65) NP_000385 No No Yes SrLFRTVLDSGISEVRa
1847.99 A-(66–80) NP_000385 No Yes Yes SDRDKFVIFLDVKHF-H20
1865.94 A-(66–80) NP_000385 No Yes Yes SDRDKFVIFLDVKHF
1938.43 A3/A1-(59–74) AAC50971 No Yes Yes SD(N)AYHIERLMSFRPIC
1963.07 A-(50–65) NP_000385 No No Yes QSrLFRTVLDSGISEVRa
2064.09 B2-(181–196) AAB25691 Yes No Yes PQVQSVRRIRDMQWHQ
2187.16 B-(2–18) NP_001876 No Yes Yes DIAIHHPWIRRPFFPFH
2359.18 B-(1–18) NP_001876 No Yes Yes Ace-MDIAIHHPWIRRPFFPFH
2598.35 ()S-(2–22) P22914 No Yes Yes Ace-SKTGTKITFYEDKNFQGRRYD
2930.62 B2-(181–204) AAB25691 Yes No Yes PQVQSVRRIRDMQWHQRGAFHPSN
3196.99 A3-(190–215) NP_005199 Yes Yes Yes GDYKHWREWGSHAQTSQIQSIRRIQQ
3252.65 A3-(189–215) NP_005199 Yes Yes Yes GGDYKHWREWGSHAQTSQIQSIRRIQQ
3389.74 A3-(188–215) NP_005199 Yes Yes Yes HGGDYKHWREWGSHAQTSQIQSIRRIQQ
aMS/MS reported an extra Arg residue, which is shown as a lowercase letter.
Crystallin Fragments Accelerate Aging and Cataract Development
8480 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283•NUMBER 13•MARCH 28, 2008
 at University of M
issouri-Colum
bia, on O
ctober 27, 2009
w
w
w
.jbc.org
D
ow
nloaded from
 
Crystallin Peptides Can Alter the Oligomerization of B- and
A-crystallins—Incubation with peptide A or peptide B
increased the mass distribution of B-crystallin (Fig. 3, A and
B). However, incubation with peptide G had no effect on the
oligomeric mass of B-crystallin (data not shown). Peptide A
and peptide B increased the average oligomeric mass of
B-crystallin by 1.23- and 5.64-fold, respectively (Table 3).
During incubation with peptide B, slight precipitation of
B-crystallin occurred. Elimination of the precipitate by cen-
trifugation caused a decrease in the peak intensity of B-crys-
tallin-peptide B complex (Fig. 3B). The polydispersity of
B-crystallin increased in response to interaction with peptide
A or B (Table 3). The hydrodynamic radius of B-crystallin
nearly doubled upon interacting with peptide B. A-crystallin
also exhibited an increase in the oligomeric mass but to a lesser
extent upon interaction with peptide A or peptide B (data not
shown). Unlike with B-crystallin, A-crystallin did not aggre-
gate on interaction with peptide B. Analysis of the A-peptide
complex recovered during gel filtration studies by SDS-PAGE
confirmed that only peptidesA andBbind toA-crystallin (Fig.
4). The results show that peptides A and B interact with A-
and B-crystallin and alter their structure and dynamics,
whereas peptide G has no effect.
Crystallin Peptides Enhance the Scattering of Light by Sub-
strate Proteins—Studies of the effects of crystallin peptides on
the thermal aggregation of substrate proteins demonstrated
that L- and -crystallins aggregated (scatter light) rapidly
upon incubation at 55 °C. The addition of peptides to the incu-
bation mixture increased the scattering of light by L in a
concentration-dependent manner (Fig. 5). At 60 g of concen-
tration, peptide A and peptide B augmented the scattering of
L-crystallin by 26 and 48%, respectively. However, peptide G
at the same concentration caused only amarginal (6%) increase
in the scattering by L-crystallin. Crystallin peptides by them-
selves did not scatter light on incubation at 55 °C. The peptides
had a similar effect on the thermal aggregation of -crystallin
(data not shown). Light scattering and aggregation experiments
were conducted for an extended time to determine the effect of
peptides A, B, and C on L-crystallin at physiological tempera-
ture. Tubes containing 250 g of L-crystallin were incubated
with 100 g of each peptide at 37 °C, and light scattering was
monitored for up to 12 h. During 37 °C incubation, peptides A
and B significantly enhanced L-crystallin aggregation,
whereas peptideG exerted very little influence (Fig. 6). The data
suggest that L- and -crystallin aggregation is enhanced upon
interaction with peptide A or B. Incubation with peptide A and
B at 37 °C also enhanced the scattering of light by ADH, a non-
crystallin substrate protein generally used in aggregation stud-
ies (data not shown).
Enhanced precipitation of L-crystallin as a result of peptide
interaction was confirmed by analyzing the aggregation precip-
itate on reverse-phase HPLC on a C-18 column. Fig. 7 shows
the protein elution profile of L-crystallin precipitate before
and after interaction with peptide B and peptide G. Protein
elution profile was similar forL-crystallin precipitate and pep-
tide G-treated L-crystallin. However, the HPLC profile
showed increased amounts of protein in peptide B-treated
L-crystallin sample, suggesting enhanced aggregation.
Although the concentration of every L-crystallin subfrac-
tion increased in the peptide B-treated sample, the increase
was significantly higher with B2 crystallin. The data indi-
cate that specific crystallin peptides found in aged lens can
interact with intact crystallins, induce their aggregation, and
lead to precipitation.
Lens Crystallin Peptides Exhibit Anti-chaperone-like Activity—
Anti-chaperone-like behavior of the crystallin fragments was
FIGURE 3. IncreasedoligomerizationofB-crystallin in response to inter-
actionwith peptides A and B. A, mass distribution across B-crystallin peak
with or without peptide A. B, mass distribution across B-crystallin peak with
orwithoutpeptideB. Chromatographic andanalysis conditions aredescribed
in the legend to Fig. 1.
TABLE 3
Effect of crystallin peptide interactions on the oligomeric size of B-crystallin determined bymultiangle light scattering
Sample Mass distributionacross peak
Mass
average Polydispersity
Hydrodynamic
radius
g/mol g/mol nm
B-crystallin 7.04e5–5.58e5 5.72e5 (0.1%) 1.003 (0.9%) 8.1 (3%)
B-crystallin peptide B 71.3e5–29.8e5 32.3e5 (0.1%) 1.056 (2%) 15.9 (0.4%)
B-crystallin peptide A 9.45e5–6.14e5 7.03e5 (0.1%) 1.006 (2%) 8.3 (0.5%)
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demonstrated by performing the thermal aggregation assay in
the presence of the peptide thatmodulated protein aggregation
and oligomerization of chaperone protein -crystallin (Fig. 8).
Without peptide, -crystallin suppressed the aggregation of
L-crystallin. However, the presence of peptide A in the aggre-
gation system reduced -crystallin chaperone activity. Simi-
larly, peptide B showed anti-chaperone-like behavior with
-crystallin in a L-crystallin aggregation assay. Suppression
of A-crystallin chaperone activity by peptide A was also
confirmed by using ADH as the aggregating protein (Fig. 9).
These results suggest that the accumulation of crystallin
peptides in the lens may interfere with the chaperone prop-
erty of -crystallin.
Peptide Sequence Specificity in Protein Aggregation-enhanc-
ing Activity—Sequence specificity of peptideA and peptide B in
influencing the aggregation of substrate proteins was deter-
mined by changing some of the residues in the native peptide
sequence. We also synthesized peptides with the reverse
sequence (retrosequence) of peptideA andpeptide B anddeter-
FIGURE 4.Demonstration of interaction of crystallin peptides A, B, and G
with A-crystallin. Incubated mixtures of A-crystallin and each peptide
were passed through a TSKG5000PWXL size exclusion column to separate the
complex. The complex peak was analyzed using 4–20% Tris-HCl SDS-polyac-
rylamide gel electrophoresis. Lane 1, molecularmassmarkers; lane 2,A-crys-
tallin  peptide G; lane 3, A-crystallin  peptide A; lane 4, A-crystallin 
peptide B. The arrow points at the peptide band.
FIGURE5.EffectsofincreasingpeptideconcentrationsonL-crystallinaggrega-
tion at 55 °C. L-Crystallin (100 g) was incubated with various concentrations of
peptideA,B,orG.A tubewithL aloneservedascontrol. Light scatteringbyL-crys-
tallinwasmonitoredat360nm.Thepercentageof the increase in light scatteringby
L-crystallin inpresenceofeachpeptideat45minwascalculatedandplotted.
FIGURE 6. Facilitated aggregation ofL-crystallin in the presence of crys-
tallin peptides A, B, and G at 37 °C. Peptide B had the greatest effect on
aggregation. A, L-crystallin alone (250 g); B, L-crystallin 100 g of pep-
tide A; C, L-crystallin  100 g of peptide B; D, L-crystallin  100 g of
peptide G; E, peptide A, B, or G (100 g).
FIGURE 7. Reverse-phase HPLC analysis ofL-crystallin aggregation pre-
cipitates in the presence of peptides A, B, and G. Black chromatogram,
aggregation precipitate of L-crystallin by itself; pink chromatogram, aggre-
gation precipitate of L-crystallin peptide G; blue chromatogram, aggrega-
tion precipitate of L-crystallin peptide B.
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mined their aggregation-inducing activity. Table 4 lists the
modified peptides that were tested for their influence on
L-crystallin aggregation. Replacement of hydrophobic resi-
dues with neutral or charged residues decreased or completely
abolished the aggregation-inducing activity of peptide A and
peptide B. Compared with native peptides, retropeptide A and
retropeptide B showed 10 and 33% decrease in L-crystallin
aggregation-enhancing activity. The data show that variants of
peptide A and peptide B sequences do not influence aggrega-
tion and light scattering to the same extent as corresponding
native peptides, indicating the importance of the peptide
sequence in crystallin aggregation. The data suggest that cer-
tain native lens peptides interact with lens crystallins, and such
interactions may contribute to crystallin aggregation in vivo.
DISCUSSION
Crystallin breakdown in the lens occurs for several reasons.
Occasionally, it is the part of the normal lens maturation proc-
ess (2). It may be due to the activation of lens proteolytic
enzymes (17, 20, 33). Nonenzymaticmechanisms are also likely
to generate crystallin fragments (34). Crystallin degradation is
also necessary for the removal of denatured proteins or
unfolded proteins that result from various oxidative stresses on
lens. Proteasomes and ubiquitin systems in the lens are
involved in the removal of oxidized proteins or peptides (35,
36). Despite this, truncated proteins/short peptides might
accumulate in the lens because of their excessive production or
because the degradation system cannot break down the frag-
ments (37–40). Earlier studies showed that the lens contains
significant quantities of crystallin fragments (6, 26), and the
complex formed by the interaction of crystallin peptides with
proteins in vivo can be modified further to form covalent mul-
timers (5). Our study confirms that young, aged, and aged cat-
aract lenses contain crystallin fragments of 3.5 kDa and that
crystallin fragmentation increases with age. Further, the data
included in our study (Table 1) show that both aged and cata-
ract lenses have increased light scattering activity compared
with the activity present in young lenses.
We could not relate the generation of LMW peptides to any
specific protease. Of 23 LMW peptides that we identified, 15
peptides are derived fromAandB-crystallin. Again, amajor-
ity of these peptides come from the N-terminal region, a few
from the -crystallin domain, and none from the C-terminal
extension. Except for peptide B, all other peptides derived from
- or -crystallin areN- or C-terminal fragments. Interestingly,
the subunit-interacting and substrate-interacting residue
sequences identified by pin-array overlap with peptide A
FIGURE 8. Inhibition of chaperone-like activity of -crystallin against
L-crystallin bypeptidesAandB. Top, anti-chaperone activity of peptideA;
bottom, anti-chaperone activity of peptide B. A, 100 g of L-crystallin; B,
L-crystallin 25 g of A-crystallin; C, L-crystallin 60 g of peptide; D,
L-crystallin A-crystallin peptide; E, peptide alone (60 g).
FIGURE9. Inhibitionof chaperone-likeactivityofB-crystallinbypeptide
B, measured against ADH substrate. A, ADH by itself, 250 g; B, ADH 20
g ofB-crystallin; C, ADH 20g of peptide B;D, ADHB-crystallin 10
gof peptide B; E, ADHB-crystallin 20gof peptide B; F, peptide alone
(20 g).
TABLE 4
Comparison of the effect of native andmutant crystallin peptides on
the scattering of light by L-crystallin
L-Crystallin (100 g) was treated with 100 g of native and mutant crystallin
peptides and incubated at 53 °C. The scattering of light by L was measured at 360
nm. The percentage increase in the light scattering against untreated L was deter-
mined during a 45-min incubation period.
Peptide Sequence
Percentage increase
in the light scattering
by L-crystallin
Native peptide A MDIAIHHPWIRRPFFPFH 73
Mutant peptide A MDIAGHHPWIRRPDFPAH 3
Mutant peptide A MDIAIHHPAGRRPFFPFH 58
Retro peptide A HFPFFPRRIWPHHIAIDM 66
Native peptide B SD(N)AYHIERLMSFRPIC 97
Mutant peptide B SD(N)ADHGERLMSFRPIC 8
Mutant peptide B SD(N)ADHGERLMSFRPGC 8
Retro peptide B CIPRFSMLREIHYA(N)DS 65
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sequence (41, 42). The B-(45–57) peptide found in the young
and aged lenses forms part of the A-crystallin recognition
sequence in B-crystallin (43). Peptides A-(66–75) and
A-(66–80) have certain residues overlapping with the chap-
erone site sequence in A-crystallin (44). Interactions between
crystallins and peptides may be limiting the action of protea-
some and peptidases on peptides, resulting in accumulation of
peptides.
Crystallin peptides of aged lenses (peptide A and peptide B)
increased the molecular mass, polydispersity, and hydrody-
namic radius ofA- andB-crystallins. Thewater-soluble frac-
tion of aged lenses showed similar increases in protein molec-
ularmass and polydispersity (Fig. 1). However, themechanisms
by which the peptides increase the molar mass of crystallin
proteins in vivo are not known. This study also showed that
binding of crystallin peptides decreased the ability of -crystal-
lin subunits to prevent aggregation of - and -crystallins and
other noncrystallin protein substrates, a process believed to be
essential for lens transparency (Figs. 8 and 9). This study is the
first to show that peptides generated in vivo can function as
anti-chaperones.Wepreviously demonstrated the anti-chaper-
one property of oxidized L-crystallin peptides generated in
vitro (27). Since peptide G did not interact with -crystallin
subunits, we believe that only certain crystallin fragments in the
aged lens interact with intact -crystallins and alter their struc-
ture and function.
To demonstrate the aggregation-enhancing property and
anti-chaperone activity of the peptides within the short assay
period, we have used a 2–10-fold molar excess of peptides over
substrate protein concentration. We were unable to determine
the exact concentration of individual peptides, but we observed
that the crystallin fragments are not uniformly distributed in
the lens. The concentration of peptides is higher in old lens
fiber cells than in younger lens fiber cells (19). Compared with
the clear region of the lens, the opaque region of the same lens
possesses a higher concentration of crystallin fragments (45).
MALDI tissue imaging of ocular lens also showed a differential
distribution of truncated crystallins in the lens (46). Therefore,
in isolated regions, the concentration of a peptide could reach
to levels sufficient enough to produce the effect. Further, the
presence of several peptides in lower concentrationmay be suf-
ficient to induce protein aggregation due to cumulative effect of
those peptides. Earlier study has shown that peptides on inter-
action induce a conformational change in the target protein
that leads to an increased exposure of hydrophobic regions,
resulting in an enhanced interaction and aggregation (29).
The process of aging and cataract development is a complex
process involving multiple factors. This study suggests that
accumulation of crystallin fragments is likely to be one of the
causes of lens aging and opacification. The peptides generated
in vivo can interact with - and -crystallin and enhance their
light scattering and precipitation. Interestingly, peptide B,
which produced more effects than peptide A, is deamidated.
Increasing concentrations of deamidated proteins and peptides
have been demonstrated in the water-insoluble fractions of
aged and cataract lenses (25, 47). To shorten the assay time in
some of our experiments, we used temperatures above physio-
logical levels to induce aggregation of - or -crystallin and
demonstrate the effects of interaction with peptides. Similar
effects were produced at physiological temperature, however,
but such assays required a longer duration. The mechanisms
that underlie the release and accumulation of age-specific pep-
tides in aged lenses are unknown. An explanation for their
accumulation may be that, upon interaction with crystallins,
peptides are not accessible to the peptidases that degrade them.
The loss of peptidase activity in aged and cataract lenses could
also lead to the accumulation of peptides (19, 40). The aggrega-
tion-influencing activity of peptides seems to be sequence-specific
and lost almost completely when hydrophobic residues are
replacedwith neutral or charged residues. The order of the amino
acids also seems to be a factor in aggregation, since the retro
sequences of peptideAandpeptideB showeddiminished capacity
to enhance L-crystallin aggregation.
These studies provide the first evidence for the role of low
molecular weight peptides in age-related cataract formation,
one of themajor protein aggregation diseases. The data suggest
that a few polypeptides (crystallin fragments) generated in the
lens during aging interact with crystallins and other proteins to
increase their light scattering, facilitate their aggregation, and act
as anti-chaperones. The results of this study of in vivo peptides
support the hypothesis that crystallin fragments generated in
vivo can facilitate protein aggregation. The initial process of
cataract formation may involve peptide fragment-mediated
loss of chaperone activity of -crystallin, protein aggregation,
and increased insolubility of lens crystallins. In previous stud-
ies, we showed that peptide interaction induces protein unfold-
ing and exposure of hydrophobic sites (29). The exposed hydro-
phobic regions of the protein may interact with each other and
further promote aggregation and increased insolubility. Taken
together, our study suggests that an interaction of hydrophobic
peptides with crystallins may be a key event in age-related pro-
tein aggregation, and cataract formation.
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